These findings reveal a mechanism where PAQR3 modulates ferroptosis through LDLR/PI3K/AKT, suggesting a potential therapeutic target in DLBCL (Song et al., 2023). The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.